KBL IV SPONSOR LLC 4
4 · 180 Life Sciences Corp. · Filed Dec 1, 2020
Insider Transaction Report
Form 4
KRAUSS MARLENE
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2020-11-18$2.31/sh−6,700$15,480→ 2,677,816 total(indirect: See footnote) - Sale
Common Stock
2020-11-25$2.78/sh−12,182$33,809→ 2,571,556 total(indirect: See footnote) - Sale
Common Stock
2020-11-17$2.26/sh−3,300$7,445→ 2,684,516 total(indirect: See footnote) - Sale
Common Stock
2020-11-23$3.26/sh−60,633$197,676→ 2,583,738 total(indirect: See footnote) - Sale
Common Stock
2020-11-19$2.12/sh−33,445$70,837→ 2,644,371 total(indirect: See footnote)
Footnotes (1)
- [F1]The shares are held directly by KBL Sponsor. Dr. Marlene Krauss, the former Chief Executive Officer, and a former memeber of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by KBL Sponsor in which she does not have a pecuniary interest.